Followers | 134 |
Posts | 7040 |
Boards Moderated | 0 |
Alias Born | 02/09/2012 |
![](https://investorshub.advfn.com/uicon/323933.png?cb=1618788139)
Friday, August 17, 2012 4:35:10 PM
Had nothing to do with efficacy of test. So yes, the person he asked would know nothing because the test did not commenced.
U of Miami was paying $3m and Prot $110k (that is thousands, a great deal) for the test costs. Prot paid the U of M the money. U of Miami had an escape clause which they exercised having nothing to do with efficacy. U of Miami was getting a very small %, believe 2% of gross sales. Rumor has it they would have considered commencing if they got a larger %. Company is said to have not wanted to give more. (if true dumb, depending on what they were asking for).
Cream launch was announced for September. They had pre-orders before and were not ready...now set for September. Marketing directly to Dr.s No reason to believe will not be on time. Would have announced by now if not in September or delay IMHO.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM